ArticleTherapeutic advances in neurological disorders2010

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.

Elliot M Frohman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.